Document is current
Any future updates will be listed below
-
Authors
Lundström, Elin
Andersson, Jonathan
Engström, Mathias
Lubberink, Mark
Strand, Robin
Ahlström, Håkan
Kullberg, Joel
-
Funding
Funding for this research was provided by:
The Swedish Research Council (2016-01040)
The Swedish Heart-Lung Foundation (2170492)
Excellence of diabetes research in Sweden
Agreement on medical education and research
Uppsala University
- License Information
-
More Information
Article History
Received: 4 June 2020
Accepted: 15 March 2021
First Online: 22 July 2021
Competing interests
: J.K. and H.A., cofounders and stockholders of Antaros Medical where they are also employed part-time. M.E., employed by GE Healthcare. M.L., cofounder of and employed part-time by Medtrace Pharma AS. M.L. and H.A. have received speaking fees and research support from GE Healthcare. J.K. has received speaking fees from Philips Healthcare. Remaining authors, no conflicts of interest.
